Physician

Mukul Gupta, M.D.

According to 2025 Medicare claims, Mukul Gupta, M.D. (NPI: 1295843738) practices hematology/oncology in the Santa Maria-Santa Barbara, CA market, with the plurality of this provider's patient population coming from Santa Barbara, CA. This provider's primary affiliated billing organization is SANSUM CLINIC (NPI: 1932121514; TIN: 956419205) and primary practice location at 93105-4230. Gupta is affiliated with the Aledade A3299 CA MSSP Enhanced (ACO ID: A3299) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 587 traditional Medicare patients, billed 198,583 HCPCS/CPT codes, and received $3,188,664 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,029 prescription claims across 204 beneficiaries totaling $3,039,578 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 81 claims. Open Payments data shows 92 records totaling $144,841. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,283,561 to $3,188,664. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,191,096 to $3,039,578. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	412	100,103	$1,283,561
2016	458	135,817	$1,847,636
2017	441	116,825	$1,818,433
2018	427	172,665	$2,365,318
2019	452	206,513	$3,154,761
2020	469	176,677	$2,891,554
2021	456	221,326	$3,488,695
2022	468	242,834	$3,275,160
2023	576	319,052	$4,209,486
2024	587	198,583	$3,188,664

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	163	1,069	$1,191,096
2016	166	1,023	$1,403,241
2017	147	717	$1,319,506
2018	135	648	$2,055,834
2019	148	867	$2,201,422
2020	149	648	$1,641,007
2021	142	672	$2,208,165
2022	171	956	$3,279,008
2023	202	1,115	$3,451,111
2024	204	1,029	$3,039,578

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	15	220	$67,998
2016	25	198	$42,825
2017	11	131	$23,197
2018	22	113	$12,697
2019	40	139	$11,123
2020	28	149	$8,646
2021	11	103	$4,678
2022	26	99	$2,744
2023	N/R	65	$8,396
2024	N/R	81	$2,084

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	97	209	$145
96413	Administration of chemotherapy into vein, 1 hour or less	103	449	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	333	766	$101
96372	Injection of drug or substance under skin or into muscle	107	356	$12
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	141	168	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	18	489	$390,739
Revlimid	Lenalidomide	18	504	$328,659
Tasigna	Nilotinib Hcl	14	392	$276,996
Nubeqa	Darolutamide	18	540	$245,968
Brukinsa	Zanubrutinib	18	540	$228,671

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8700	Temozolomide, oral, 5 mg	N	N/R	13	$759
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	25	$471
J8521	Capecitabine, oral, 500 mg	N	N/R	16	$407
J8999	Prescription drug, oral, chemotherapeutic, nos	N	N/R	11	$247
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$201

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$737	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	63	$144,104	BioNTech SE
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mukul Gupta, M.D.?

Tedicare shows public-source Medicare data for Mukul Gupta, M.D. (NPI 1295843738), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mukul Gupta, M.D. have ACO affiliation data?

Mukul Gupta, M.D. is shown with ACO affiliation data for Aledade A3299 CA MSSP Enhanced (MSSP, ACO ID A3299) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Mukul Gupta, M.D.?

Mukul Gupta, M.D. is linked to SANSUM CLINIC (billing NPI 1932121514) in the available physician profile data.

Does Mukul Gupta, M.D. have Open Payments data?

Mukul Gupta, M.D. has 92 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.